|
Harte Hanks, Inc. (HHS): Marketing Mix Analysis [Dec-2025 Updated] |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Harte Hanks, Inc. (HHS) Bundle
You're trying to map out where Harte Hanks, Inc. stands right now, and honestly, the financials tell a tough story: Q3 revenue slid 17.0% year-over-year to $39.5 million. As an analyst, I see them aggressively trying to turn that ship with cost optimization targeting $16 million in savings while simultaneously pushing new digital products and a recent health data acquisition. So, to see if the strategy matches the need, let's cut through the noise and look at their core Product, Place, Promotion, and Price setup below, because understanding the 4 Ps is key to judging their next move.
Harte Hanks, Inc. (HHS) - Marketing Mix: Product
You're looking at the core offerings from Harte Hanks, Inc. as of late 2025. The product element centers on services delivered across three primary operational pillars: Marketing Services, Customer Care, and Fulfillment & Logistics Services. This structure supports a data-driven CX strategy, where investments are prioritized in areas like agent training, AI, and customer data platforms to generate actionable insights for clients. The company reported total revenue of $39.5 million for the third quarter ended September 30, 2025, against a net loss of $(2.3) million for the same period. The company maintains zero debt outstanding as of Q3 2025, holding $6.5 million in cash and cash equivalents.
The composition of the product offering, based on Q3 2025 revenue, shows the relative weight of each segment:
| Core Segment | Q3 2025 Revenue (Millions USD) | Year-over-Year (YoY) Change (3 Months Ended Sept 30, 2025) |
| Fulfillment & Logistics Services | $19.1 | Decrease of 10.2% |
| Customer Care | $11.6 (Calculated) | Decrease of 11.6% (Based on Q3 data context, Q1 2025 saw a 4.5% increase YoY) |
| Marketing Services | $8.8 | Decrease of 33.4% |
The digital service portfolio, largely housed within Marketing Services, is built around performance and intent-focused campaigns. Harte Hanks, Inc. offers comprehensive solutions designed to reach B2B and B2C audiences effectively. These digital offerings are key components of their execution capability.
- Account Based Marketing (ABM) for scaling influence with A-list accounts.
- Paid Social media marketing across platforms like Facebook, TikTok, Instagram, YouTube, and LinkedIn.
- Search Engine Marketing (SEM), including Pay-Per-Click (PPC) services.
The company bolsters its sales and support capabilities through specialized outsourcing and technology integration. The Inside Sales Outsourcing service leverages professionals and experimentation to optimize the sales funnel, from lead generation to closing. This capability was enhanced by the prior acquisition of InsideOut Solutions for $7.5 million. For Customer Care, the product includes technology management solutions, such as conversational IVR systems and real-time analytics, designed to lower the cost of support interactions. Customer Care segment revenue in Q1 2025 was $13.0 million, showing a 4.5% increase from the previous year.
A significant recent addition to the product suite is proprietary data licensing, which enhances precision targeting, especially in healthcare. On June 2, 2025, Harte Hanks, Inc. obtained exclusive rights to license the ADS Data Direct's Medical Ailment Database. This asset is notable because it contains self-reported information from consumers who are 100% triple opt-in and covers more than 200 ailment categories, including diabetes and heart disease. The database is explicitly noted as being HIPAA-compliant, which is critical for pharmaceutical and medical device clients.
Harte Hanks, Inc. (HHS) - Marketing Mix: Place
Harte Hanks, Inc. deploys a global service delivery model to support its integrated, omnichannel, and data-driven marketing services across diverse industries.
- Industries served include B2B, retail, consumer, finance, healthcare, travel and leisure, automotive, entertainment, technology, and insurance.
- The business presence spans North America, Europe, and Asia-Pacific.
- Harte Hanks, Inc. operates with 8 offices across 5 different countries.
The corporate headquarters is established at 1 Executive Drive, Suite 303, Chelmsford, Massachusetts 01824.
Key US operational centers are associated with former or current subsidiary locations in:
- Dallas, Texas (Harte-Hanks Direct Marketing/Dallas, L.P.)
- Jacksonville, Florida (Harte-Hanks Direct Marketing/Jacksonville, LLC)
- Fullerton, California (Harte-Hanks Direct Marketing/Fullerton, Inc.)
A new Customer Care center was opened in Greenville, SC, announced on October 21, 2025, in partnership with Samsung Electronics America, Inc. The facility is 15,000 square feet and is expected to support more than 150 new jobs.
The international presence includes a subsidiary in Brazil, specifically Harte-Hanks Do Brazil Consoltoria E Servicos LTDA, which holds 100% ownership.
The distribution of Harte Hanks, Inc. physical locations and service reach can be summarized as follows:
| Location Type | Specific Location/Entity | Associated Metric/Detail |
|---|---|---|
| Corporate Headquarters | Chelmsford, Massachusetts | 1 Executive Drive, Suite 303, 01824 |
| Key US Operational Center | Dallas, Texas | Harte-Hanks Direct Marketing/Dallas, L.P. |
| Key US Operational Center | Jacksonville, Florida | Harte-Hanks Direct Marketing/Jacksonville, LLC |
| Key US Operational Center | Fullerton, California | Harte-Hanks Direct Marketing/Fullerton, Inc. |
| New Customer Care Center (Oct 2025) | Greenville, South Carolina | 15,000 sq. ft.; Supporting >150 jobs |
| International Subsidiary | Brazil | Harte-Hanks Do Brazil Consoltoria E Servicos LTDA |
| Global Footprint | Total Offices/Countries | 8 offices in 5 countries |
For the three months ended September 30, 2025, the Customer Care segment reported a revenue decrease of 11.6%. The total revenue for the quarter ending September 30, 2025, was $39.5 million.
Harte Hanks, Inc. (HHS) - Marketing Mix: Promotion
Promotion for Harte Hanks, Inc. centers on demonstrating tangible results from its data-driven customer experience (CX) strategy, particularly through high-profile client engagements and internal investment programs that support sales execution.
Strategic focus on new client wins in healthcare, tech, and automotive is a core promotional narrative. In the first quarter of 2025, Harte Hanks reported achieving strategic client wins across key industries, specifically naming healthcare and technology. The company's established client base includes major players in healthcare such as GSK, Abbott, Blue Cross/Blue Shield, and Pfizer. Furthermore, Harte Hanks supports customers across the automotive sector.
The internal transformation program, Project Elevate, directly supports sales investment by focusing on operational efficiencies and growth. Introduced to enhance performance and profitability, Project Elevate emphasizes increased investment in sales and marketing. This focus is set against a backdrop where the Marketing Services segment saw a revenue drop of 35.3% in Q1 2025, making the investment in sales pipeline and lead generation critical.
Securing strategic partnerships serves as a major promotional event. The announcement on October 21, 2025, of the new Customer Care center in Greenville, South Carolina, in partnership with Samsung Electronics America, was a significant event. This initiative will support more than 150 new jobs. The market reacted strongly to this news, with Harte Hanks stock gaining 72.91% on the day of the announcement. David Fisher, President of Harte Hanks, indicated a commitment to growing this relationship across the globe.
The promotion emphasizes the company's capability in data-driven insights and seamless program execution, which is central to its service offering. For one technology client, the data services program translated into tens of billions of records generated, processed, and delivered each year.
Here is a look at some key financial and operational metrics that frame the investment in promotion and sales support:
| Metric | Value / Period | Context |
| Q3 2025 Revenue | $39.5 million | Compared to $47.6 million in Q3 2024 |
| Q2 2025 Total Revenue | $38.6 million | A 14.2% decrease from the previous year |
| Q1 2025 Marketing Services Revenue Change | -35.3% | Due to reduced project work and expiring contracts |
| Samsung Partnership Job Creation | More than 150 new jobs | In Greenville, South Carolina facility |
| Q1 2025 Cash Balance | $9.0 million | Company maintained a debt-free balance sheet |
The promotional message highlights the execution capabilities across service lines:
- Securing exclusive rights to license ADS Data Direct's Medical Ailment Database for healthcare marketing.
- Leveraging data services to identify up to 100K customer or consumer prospects each month for a technology client.
- Focus on expanding lead generation activities to drive revenue growth.
- Maintaining a global team of over 2,500+ associates.
The reorganized sales structure is aligned to support these segments, aiming to convert the strengthened pipeline into revenue, which is necessary given the Q3 2025 revenue of $39.5 million.
Harte Hanks, Inc. (HHS) - Marketing Mix: Price
You know that for Harte Hanks, Inc., the price you charge isn't a simple sticker number; it's tied directly to the nature of the work. Revenue is inherently contract and project-based, so you see volatility quarter-to-quarter. This structure means pricing strategy has to be flexible enough to capture value but stable enough to manage internal cost structures.
Looking at the recent top line, Harte Hanks, Inc. reported total revenue for the third quarter ending September 30, 2025, was $39.5 million. That figure represents a 17.0% year-over-year decline. This revenue performance reflects the ongoing challenge of securing consistent, high-volume project work across the board.
To give you a clearer picture of where the revenue was coming from in the first quarter of 2025, here's the segment breakdown. Note that the Fulfillment & Logistics Services segment was the largest contributor that quarter:
| Segment | Q1 2025 Revenue | Year-over-Year Change (Q1 2025 vs Q1 2024) |
|---|---|---|
| Fulfillment & Logistics Services | $19.8 million | 1.8% increase |
| Customer Care | $13.0 million | 4.5% increase |
| Marketing Services | $8.8 million | -35.3% decline |
Given the revenue pressures, cost optimization is a key priority, driven by the transformation program called Project Elevate. This initiative is targeting approximately $16 million in reorganization savings across the 2024 to 2026 timeframe. For the third quarter of 2025 alone, restructuring charges related to Project Elevate were $0.5 million, showing the immediate investment required for future efficiency.
Your pricing structure absolutely must cover your underlying costs, which are currently under adjustment. The company is actively managing its cost base; for instance, operating expenses for the three months ended September 30, 2025, decreased by 14.7%, reflecting cost controls and adjustments in labor and production expenses in response to reduced revenue. This means your quoted prices need to align with these shifting internal costs while remaining competitive in the market.
The reality of pricing for Harte Hanks, Inc. involves several moving parts:
- Revenue is contract and project-based, leading to volatility.
- Pricing must reflect adjusted labor and production costs.
- Cost controls, like those in Project Elevate, influence margin targets.
- Q3 2025 total revenue was $39.5 million.
- Q1 2025 Fulfillment & Logistics revenue was $19.8 million.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.